Single chain peptide agonists of relaxin receptors

Praveen Praveen; Martina Kocan; Adam Valkovic; Ross Bathgate; Mohammed Akhter Hossain

Journal article

Single chain peptide agonists of relaxin receptors

Praveen Praveen, Martina Kocan, Adam Valkovic, Ross Bathgate, Mohammed Akhter Hossain

Molecular and Cellular Endocrinology | ELSEVIER IRELAND LTD | Published : 2019

DOI: 10.1016/j.mce.2019.01.008

University of Melbourne Researchers

Akhter Hossain Author Florey Department of Neuroscience and Mental Health

Ross Bathgate Author Florey Department of Neuroscience and Mental Health

Martina Kocan Author Florey Department of Neuroscience and Mental Health

Related Projects (3)

Novel insulin to treat diabetes

The glucose regulatory hormone, insulin, remains the only treatment for type I diabetes and up to 30% of type II diabetes, both of which are..

INTERROGATING PEPTIDE RECEPTOR TARGETS

The neuropeptide relaxin-3 and the peptide hormone INSL5 are recently discovered members of the relaxin peptide family. Relaxin-3 has import..

UNRAVELLING THE BINDING AND ACTIVATION MECHANISM OF A COMPLEX G PROTEIN-COUPLED RECEPTOR

The peptide hormone relaxin is currently in a Phase III trial for the treatment of heart failure. However the peptide is not a good drug as ..

Grants

Awarded by NHMRC (Australia)

Funding Acknowledgements

This research was partly funded by NHMRC (Australia) project grants (1122170, 1023321, 1065481, and 1100676) to M.A.H. and R.A.D.B. Research at The Florey Institute of Neuroscience and Mental Health is supported by the Victorian Government Operational Infrastructure Support Program.